Skip to content

Evaluation of intrauterine infusion of autologous platelet rich plasma (PRP) on in vitro fertilization (IVF)

Clinical trial of pregnancy outcome in women with thin endometrium after intrauterine infusion of autologous platelet rich plasma (PRP) in comparison with women with thin endometrium without intervention undergoing frozen thawed cycles

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016090328950N2
Enrollment
66
Registered
2017-01-10
Start date
2016-09-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

female infertility. female infertility unspecified

Interventions

Intervention 1: Intervention group: In 2nd day of cycle the patients undergo a basic trans vaginal sonography. For all the women who enter in frozen thawed cycles, estradiol tablet 2mg three times dai
Treatment - Drugs
Intervention group: In 2nd day of cycle the patients undergo a basic trans vaginal sonography. For all the women who enter in frozen thawed cycles, estradiol tablet 2mg three times daily is initiated.
Control group: In 2nd day of cycle the patients undergo a basic trans vaginal sonography. For all the women who enter in frozen thawed cycles, estradiol tablet 2mg three times daily is initiated. In 1

Sponsors

Shahid Sadoughi University of Medical Sciences, Vice chancellor for research
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 42 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: women undergoing frozen thawed cycles; endometrial thickness less than 7 mm in 13 th day of cycle; age between 18 to 42 Exclusion criteria: hematological and immunological disorders; hormonal disorders; chromosomal and genetic abnormalities; uterine abnormalities (congenital or acquired)

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Endometrial thickness. Timepoint: 13th, 15th day of menstural cycle and in some patients 17th day of cycle. Method of measurement: trans vaginal sonograghy.

Secondary

MeasureTime frame
Chemical pregnancy. Timepoint: 2 weeks after embryo transfer. Method of measurement: serum pregnancy test.;Clinical pregnancy. Timepoint: 4 weeks after embryo transfer. Method of measurement: trans vaginal sonograghy.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Nosrat Neghab

Yazd research and clinical center for infertility Shahid sadoughi university of medical sciences

nosratneghab@ssu.ac.ir; nosrat20@yahoo.com+98 35 1824 7085

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026